Baron Partners Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell Midcap Growth Index.

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

The author of the zeitgeisty non-fiction books “Why We Can’t Sleep” and “And Also a Poet” has written her first novel. A husband and wife with a fulfilling partnership and family life ...

Looking for a book recommendation? The "GMA" Book Club library is filled with bestselling picks, from novels that transported us to far off places, to characters which have made us see the world in a ...

Here are T&C’s picks for the best books of February 2025. Olivia Wolfgang-Smith's sophomore novel, Mutual Interest, is set shortly after the Gilded Age in New York City. The story is a queer ...

Veterinary diagnostics specialist Idexx Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for ...

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the consensus of $2.40. The pet healthcare company reported sales of $954.3 ...

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.